Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC

Journal of Endocrinology

Volumn 202, Issue 1, 2009, Pages 111-121

  Hotta, Kikuko ^a   Hosaka, Masahiro ^b   Tanabe, Atsushi ^a   Takeuchi, Toshiyuki ^b  

^a RIKEN   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; OREXIN; PEPTIDE HORMONE; PROOPIOMELANOCORTIN; SECRETOGRANIN II; SECRETOGRANIN III; UNCLASSIFIED DRUG; CHROMOGRANIN; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOSOL; EXPERIMENTAL MOUSE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LATERAL HYPOTHALAMUS; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; THALAMUS MIDLINE NUCLEUS; TWO HYBRID SYSTEM; ANIMAL; C57BL MOUSE; CELL CULTURE; FOOD INTAKE; HUMAN; HYPOTHALAMUS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETORY VESICLE;

ANIMALS; APPETITE REGULATION; CELLS, CULTURED; CHROMOGRANINS; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NEUROPEPTIDE Y; NEUROPEPTIDES; PRO-OPIOMELANOCORTIN; PROTEIN BINDING; SECRETOGRANIN II; SECRETORY VESICLES;

EID: 67650713778     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0531     Document Type: Article

References (25)

1. Ang CW, Dotman CH, Winkler H, Fischer-Colbrie R, Sonnemans MA & Van Leeuwen FW 1997 Specific expression of secretogranin II in magnocellular vasopressin neurons of the rat supraoptic and paraventricular nucleus in response to osmotic stimulation. Brain Research 765 13-20.
2. Barsh GS, Farooqi IS & O'Rahilly S 2000 Genetics of body-weight regulation. Nature 404 644-651.
3. Beuret N, Stettler H, Renold A, Rutishauser J & Spiess M 2004 Expression of regulated secretory proteins is sufficient to generate granule-like structures in constitutively secreting cells. Journal of Biological Chemistry 279 20242-20249.
4. Chan JL & Mantzoros CS 2005 Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 366 74-85.
5. Dina C, Meyre D, Gallina S, Durand E, Körner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C et al. 2007 Variation in FTO contributes to childhood obesity and severe adult obesity. Nature Genetics 39 724-726.
6. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW et al. 2007 A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 889-894.
7. Gerken T, Girard CA, Tung YC,Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA et al. 2007 The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318 1469-1472.
8. Han L, Suda M, Tsuzuki K, Wang R, Ohe T, Hirai H, Watanabe T, Takeuchi T & HosakaM2008 A large form of secretogranin III functions as a sorting receptor for chromogranin A aggregates in PC12 cells. Molecular Endocrinology 22 1935-1949.
9. Hervé C, Colard C, Grillon S, Fellmann D & Griffond B 1998 Polyethylene glycol-induced hypovolemia affects the expression of MCH mRNA, but not dynorphin or secretogranin II mRNAs, in the rat lateral hypothalamus. Neuroscience Letters 248 133-137.
10. Hosaka M, Watanabe T, Sakai Y, Kato T & Takeuchi T 2005 Interaction between secretogranin III and carboxypeptidase E facilitates prohormone sorting within secretory granules. Journal of Cell Science 118 4785-4795.
11. Hotta K, Nakata Y, Matsuo T, Kamohara S, Kotani K, Komatsu R, Itoh N, Mineo I, Wada J, Masuzaki H et al. 2008 Variations in the FTO gene are associated with severe obesity in the Japanese. Journal of Human Genetics 53 546-553.
12. Kopelman PG 2000 Obesity as a medical problem. Nature 404 635-643.
13. Maes HH, Neale MC & Eaves LJ 1997 Genetic and environmental factors in relative body weight and human adiposity. Behavior Genetics 27 325-351.
14. Mahata SK, Mahata M, Steiner HJ, Fischer-Colbrie R & Winkler H 1992 In situ hybridization: mRNA levels of secretogranin II, neuropeptides and carboxypeptidase H in brains of salt-loaded and Brattleboro rats. Neuroscience 48 669-680.
15. Matsuzawa Y, Funahashi T & Nakamura T 1999 Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Annals of the New York Academy of Sciences 892 146-154.
16. Ottiger HP, Battenberg EF, Tsou AP, Bloom FE & Sutcliffe JG 1990 1B1075: a brain- and pituitary-specific mRNA that encodes a novel chromogranin/secretogranin-like component of intracellular vesicles. Journal of Neuroscience 10 3135-3147.
17. Rankinen T, Zuberi A, Chagnon YC,Weisnagel SJ, Argyropoulos G,Walts B, Pérusse L & Bouchard C 2006 The human obesity gene map: the 2005 update. Obesity 14 529-644.
18. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ & Baskin DG 2000 Central nervous system control of food intake. Nature 404 661-671.
19. Scuteri A, Sanna S, Chen WM, UdaM, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G et al. 2007 Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genetics 3 1200-1210.
20. Song L & Fricker LD 1995 Calcium- and pH-dependent aggregation of carboxypeptidase E. Journal of Biological Chemistry 270 7963-7967.
21. Takeuchi T & Hosaka M 2008 Sorting mechanism of peptide hormones and biogenesis mechanism of secretory granules by secretogranin III, a cholesterol-binding protein, in endocrine cells. Current Diabetes Reviews 4 31-38.
22. Tanabe A, Yanagiya T, Iida A, Saito S, Sekine A, Takahashi A, Nakamura T, Tsunoda T, Kamohara S, Nakata Yet al. 2007 Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) gene that form secretory granules with appetite-related neuropeptides are associated with obesity. Journal of Clinical Endocrinology and Metabolism 92 1145-1154.
23. Taupenot L, Harper KL & O'Connor DT 2003 The chromogranin-secretogranin family. New England Journal of Medicine 348 1134-1149.
24. Wilson PW & Grundy SM 2003 The metabolic syndrome: a practical guide to origins and treatment: part I. Circulation 108 1422-1424.
25. Yanagiya T, Tanabe A, Iida A, Saito S, Sekine A, Takahashi A, Tsunoda T, Kamohara S, Nakata Y, Kotani K et al. 2007 Association of single-nucleotide polymorphisms in MTMR9 gene with obesity. Human Molecular Genetics 16 3017-3026.